7thirty Capital Research
Investment Thesis
7thirty Capital is a specialized venture capital fund focused exclusively on cannabis technology and cannabis-adjacent opportunities in regulated frontier markets. The firm invests in med-tech, ag-tech, SaaS solutions, marketplaces, and deep-tech companies across the cannabis value chain. The fund does not invest in plant-touching (direct cultivation) businesses but rather in the technology and infrastructure that enables the cannabis industry to operate efficiently and compliantly in regulated markets.
Led by Micah Tapman, a veteran of the cannabis industry who previously co-founded and led the CanopyBoulder accelerator program, 7thirty has developed deep expertise in cannabis regulatory landscapes across US states, Canada, and Israel. The firm takes a hands-on approach, providing not just capital but also operational and strategic guidance on navigating the unique regulatory and market challenges of cannabis.
Sector Focus
7thirty invests across multiple cannabis-related technology verticals:
Cannabis Software & Compliance:
- Compliance and transparency platforms (e.g., Flourish Software)
- Inventory management and tracking systems
- Point-of-sale and retail management tools
- Data analytics and market intelligence (e.g., BDSA)
Agricultural Technology:
- Greenhouse tech and cultivation optimization (e.g., Trym)
- Plant pathogen detection and prevention (e.g., deepgreen.ai)
- Rapid testing and pathogen detection (e.g., PathogenDX)
Cannabis Accessories & Consumer Products:
- Harm reduction and safe vaping hardware (e.g., Blinc)
- CBD-infused consumer brands (e.g., Weller)
B2B Commerce & Logistics:
- Cannabis wholesale trading platforms (e.g., Apex Trading)
- Supply chain and logistics solutions
- Flexible working capital financing (e.g., Lendica)
Adjacent Deep-Tech:
- Image recognition and AI for agriculture
- Chemicals R&D for cannabis applications
- Innovative building materials for cultivation
Stage Focus
7thirty is an early-stage fund that primarily invests at Seed and Series A stages:
- Pre-Seed: $500K-$1.5M for founding teams with strong vision
- Seed: $1M-$3M for companies with working products and early adoption
- Series A: Selective participation in follow-on rounds for portfolio companies
The fund has a strong preference for being an early investor and establishing deep relationships with founding teams.
Check Size
Typical investment range: $1M - $3M
- Early-stage: $500K-$1.5M for pre-seed
- Core range: $1M-$3M for seed rounds
- Occasional larger checks for co-led Series A rounds
Lead Tendency
7thirty operates as a lead investor in seed-stage deals, often co-leading rounds with other specialized cannabis venture funds like Delta Emerald Ventures and Welcan Capital. They have established themselves as a trusted source of capital in the cannabis technology ecosystem and frequently take meaningful board participation.
Recent Activity (2019-2025)
7thirty has been consistently active in deploying capital into cannabis tech startups:
Notable Portfolio Investments:
- Flourish Software (2019) - Cannabis compliance and transparency, Seed: $2.35M
- Apex Trading (2019) - B2B cannabis wholesale platform, Seed: $1.67M
- Trym (2020) - Agricultural tech for greenhouses, Seed: $3.1M (co-led with Delta Emerald)
- Azara (2022) - Cannabis cultivation management software, participated in $3.1M seed
- BDSA (ongoing) - Cannabis market research and data analytics, BDS Analytics is a portfolio company
Fund Status: Actively deploying from their primary fund (7thirty Opportunity Fund). The fund has been raising capital from strategic investors and family offices interested in the cannabis technology space. Micah Tapman has been featured at major cannabis industry conferences (Prohibition Partners) and continues to lead the firm's investment activities.
Portfolio Highlights
7thirty has built a concentrated portfolio of 12+ cannabis technology companies across critical infrastructure areas:
- Compliance layer: Flourish Software (award-winning, featured in ATL Startups to Watch 2026)
- Data & Intelligence: BDSA (leading market research platform used across industry)
- Agriculture: Trym (greenhouse optimization), deepgreen.ai (plant pathogen detection), PathogenDX
- B2B Commerce: Apex Trading (wholesale platform), Lendica (working capital)
- Consumer: Blinc (safe vaping), Weller (CBD products)
- Chemical R&D: Kelsie Biotech
- Infrastructure: Revive Industries (building materials for cultivation)
The portfolio demonstrates a clear focus on the "picks and shovels" strategy—enabling the cannabis industry without touching the plant itself.
Team
Micah Tapman, Managing Partner & Co-founder: A 15+ year veteran of the cannabis industry with deep expertise in venture capital. Previously co-founded and served as Managing Director of CanopyBoulder, a leading cannabis accelerator program. Has directly led investments in 90+ cannabis companies across multiple sectors. Background in cybersecurity and finance provides a pragmatic, data-driven approach to deal evaluation. Active mountaineer and travel enthusiast.
Jamul Jadamba, Managing Partner & Co-founder: Extensive background in finance and investment banking, having worked at major firms including Oppenheimer on Wall Street. Brings expertise in commodities trading and investment banking operations. Leads 7thirty's investment banking and financial engineering operations.
Ben Richardson, Research Director: Former analyst at leading financial firms including J.P. Morgan and Susquehanna with deep commodities expertise. Brings both hard-nosed research capabilities and cultural understanding of the cannabis sector (California roots). Combines rigorous due diligence with practical knowledge of industry dynamics.
Geographic Focus
7thirty operates globally across regulated cannabis markets:
- United States: Primary focus on Colorado (HQ location), California, and other major cannabis markets with established regulatory frameworks
- Canada: Significant investment activity in Canadian cannabis tech ecosystem
- Israel: Emerging market with advanced cannabis research and biotech capabilities
The firm explicitly focuses on markets with legal, regulated cannabis industries and does not invest in jurisdictions with prohibition or unclear legal status.
Decision Process
7thirty operates as a partnership-driven fund with:
- Multiple decision makers (Micah Tapman and Jamul Jadamba as managing partners)
- Technical diligence led by Ben Richardson's research team
- Board participation and hands-on operational support post-investment
- Average decision timeline: 2-4 weeks for seed-stage deals
Investment Philosophy
Pro: 7thirty's thesis is that the cannabis industry is fundamentally a technology and compliance problem, not a consumer retail problem. They focus on unsexy but essential infrastructure: software, hardware, data, and supply chain systems. They've built deep relationships with regulatory agencies and industry operators.
Against: 7thirty avoids plant-touching businesses entirely, consumer-focused applications without technology differentiation, and highly capital-intensive infrastructure plays.
Founder Preferences
7thirty backs:
- Technical founders with cannabis industry experience or willingness to learn
- Pragmatic teams focused on solving real operational problems
- Founders who understand cannabis regulation and compliance requirements
- Experienced operators, particularly from adjacent industries (agriculture, pharma, finance)
- Teams with successful exits or demonstrated execution capability
Notable Exits & Milestones
- BDS Analytics: Acquired and became a leading platform used across the industry (still active as portfolio company)
- Multiple Seed-to-Series A progressions: Portfolio companies including Flourish, Trym, and others advancing to growth stages
- Industry Leadership: Micah Tapman recognized as a leading voice in cannabis venture investing at major industry events